Capricor Therapeutics (CAPR) Q4 2023 Earnings

29FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.35
-0.24
-0.13
-0.02

Details

Expected EPS
-0.09
Actual EPS
-0.02
Surprise EPS
0.07
Surprise Percent
+77.78%

Description

Capricor Therapeutics (CAPR) has reported earnings of -0.02 per share for Q4 2023.

0 Comments

Share your thoughts